Patent №
US 11,208,697
Granted
2021-12-28
Filed 2018
Owner
GENOMEDX BIOSCIENCES, INC.
+4 more
Lab
—
AI components
2
nlp · kr
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15875871
The present invention relates to methods, systems and kits for the diagnosis, prognosis, and treatment of bladder cancer in a subject. The invention also provides biomarkers that define subgroups of bladder cancer, clinically useful classifiers for distinguishing bladder cancer subtypes, bioinformatic methods for determining clinically useful classifiers, and methods of use of each of the foregoing. The methods, systems and kits can provide expression-based analysis of biomarkers for purposes of subtyping bladder cancer in a subject. Further disclosed herein, in certain instances, are probe sets for use in subtyping bladder cancer in a subject. Classifiers for subtyping a bladder cancer are provided. Methods of treating bladder cancer based on molecular subtyping are also provided.
AI classification
Ownership
GENOMEDX BIOSCIENCES, INC.
assignment · 456040148
DECIPHER BIOSCIENCES, INC.
namechg · 485390776
GENOMEDX INC.
namechg · 485390868
THE UNIVERSITY OF BRITISH COLUMBIA
assignment · 515350611
VERACYTE SD, INC.
namechg · 656270138
Assignors
DAVICIONI, ELAI, ASHAB, HUSSAM AL-DEEN, ERHO, NICHOLAS, BLACK, PETER
On an employer assignment, the assignors are typically the inventors.